Valence Advantage Life Sciences Fund II, LP
Valence Life Sciences · adviser of record: Valence Life Sciences, LLC · 2012 vintage
Valence Advantage Life Sciences Fund II, LP is a 2012 venture fund managed by Valence Life Sciences. It reported $59.4mm in gross assets at year-end 2012, its highest reported value.
- Latest value held
- $59.4mm year-end 2012
- Peak
- $59.4mm year-end 2012
- Fund size
- Not on file
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2012 | $59.4mm | – | – |
Other funds from Valence Life Sciences
- Valence Helix Investments III 2018
- Valence Helix Investments II 2018
- Valence Helix Investments I 2018
- Valence Advantage Life Sciences Side Fund II, LP 2012
- Caxton Advantage Life Sciences Fund, L.P. 2011
All Valence Life Sciences funds
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-3436476673. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.